SKOKIE, IL--(MARKET WIRE)--Jun 23, 2008 -- NanoGuardian(TM), a division of NanoInk® that focuses exclusively on delivering brand protection solutions to fight illegal diversion and counterfeiting, announced today that the Food and Drug Administration (FDA) has issued approval to a NanoGuardian client to use NanoGuardian's cutting edge NanoEncryption(TM) technology as an on-dosage, brand protection technology. NanoGuardian's NanoEncryption technology provides pharmaceutical manufacturers with true forensic, multi-layered, authentication and tracing brand protection at the individual dosage level.
